ASSAY and Drug Development Technologies
基本信息
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: Assay design, target development, and high-throughput technologies Hit to Lead optimization and medicinal chemistry through preclinical candidate selection Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis Approaches to assays configured for gene families, inherited, and infectious diseases Assays and strategies for adapting model organisms to drug discovery The use of stem cells as models of disease Translation of phenotypic outputs to target identification Exploration and mechanistic studies of the technical basis for assay and screening artifacts The Journal also features a dedicated Drug Repurposing, Rescue, and Repositioning (DRRR) section. These special peer-reviewed collections of papers present techniques and tools for finding new uses for approved drugs – particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified. This DRRR special section features original papers, application-oriented technology reviews, and reports in methodology and technology application to drug repurposing and redevelopment including: Designing assays and interpreting output to enable alternate drug target identification Pathway analysis and bioinformatics to identify and exploit drug promiscuity In silico technologies to identify alternate drug targets "Big Data" mining and side effect pattern analysis in clinical and healthcare repositories
CiteScore
| 学科 | 排名 | 百分位 |
|---|---|---|
Pharmacology, Toxicology and PharmaceuticsDrug Discovery |
93 / 146 | 36% |
期刊统计
投稿信息
投稿网址:
https://mc.manuscriptcentral.com/assay期刊推荐

Colloid Journal

Chinese Journal of Chemistry

Heteroatom Chemistry

Critical Reviews in Solid State and Materials Sciences

Topics in Catalysis

Journal of Asian Natural Products Research

Acta Metallurgica Sinica-English Letters

Journal of Chemical Sciences

Polycyclic Aromatic Compounds

Medicinal Chemistry Research
相关文献
Sn(iv) phosphonates as catalysts in solvent-free Baeyer–Villiger oxidations using H2O2
Sharath Kirumakki, Sandani Samarajeewa, Robert Harwell, Atashi Mukherjee, Rolfe H. Herber, Abraham Clearfield
DOI: 10.1039/B807938B
Aqueous dispersions of TCNQ-anion-stabilized graphene sheets
Rui Hao, Wen Qian, Luhui Zhang, Yanglong Hou
DOI: 10.1039/B816971C
Reversible colorimetric ion sensors based on surface initiated polymerization of photochromic polymers
Kristen Fries, Satyabrata Samanta, Sara Orski, Jason Locklin
DOI: 10.1039/B818042C
Synthesis of tri- and tetraynes using a butadiynyl synthon
Khalid Azyat, Eike Jahnke, Trent Rankin, Rik R. Tykwinski
DOI: 10.1039/B816177A
Remarkable switching behavior of bimodally stimuli-responsive photochromic dithienylethenes with redox-active organometallic attachments
Keiko Motoyama, Takashi Koike, Munetaka Akita
DOI: 10.1039/B809318K
Trimacrocyclic arylamine and its polycationic states
Akihiro Ito, Yuko Yamagishi, Koji Fukui, Syuuzi Inoue, Yasukazu Hirao, Ko Furukawa, Tatsuhisa Kato
DOI: 10.1039/B816311A
Epoxy functionalised poly(ε-caprolactone): synthesis and application
Jiaxiang Zhou, Wenxin Wang, Silvia Villarroya, Kristofer J. Thurecht, Steven M. Howdle
DOI: 10.1039/B810297J
Synthesis and structural characterisation of a soluble, metastable indium(i) halide complex, [InBr(tmeda)]
Cameron Jones, Andreas Stasch
DOI: 10.1039/B814658F
Highly regioselective ring-opening of trisubstituted aziridines by sulfur-stabilised carbanions
Santiago Carballares, Donald Craig, Christopher J. T. Hyland, Pengfei Lu, Tanya Mathie, Andrew J. P. White
DOI: 10.1039/B815971H
您可能还喜欢
4-[4-三氟甲基苯基]恶唑(CAS号:1126636-40-5)通常如何合成?
4-[4-三氟甲基苯基]恶唑通常通过将4-三氟甲基苯酚与异硫氰酸苯酯在有机溶剂中进行酯化反应合成。该反应可在无水条件下,使用适当的催化剂,如四丁基氢氧化铵,以提...
RockPhos Pd G3(CAS号:2009020-38-4)通常如何合成?
RockPhos Pd G3 通常通过钯催化偶联反应合成,使用配体 (2'-Amino-2-biphenylyl)(methanesulfonato-kappa...
1-哌啶甲酰胺(CAS号:2158-03-4)的市场或研究趋势如何?
1-哌啶甲酰胺作为有机合成中的重要中间体,其市场需求主要受医药、农药、染料等行业推动。近年来,随着新药开发和绿色化学的发展,该化合物的研究趋势集中在开发更高效、...
2-(二苯基膦基)乙胺(CAS号:4848-43-5)适用哪些法规指南?
2-(二苯基膦基)乙胺适用于多种法规指南,包括但不限于《全球化学品统一分类和标签制度》(GHS),欧盟《化学品注册、评估、授权和限制》法规(REACH),以及美...
如何储存间苯二甲酸二烯丙酯(CAS号:1087-21-4)?
间苯二甲酸二烯丙酯应储存在阴凉、干燥、通风良好的地方,远离火源和热源。储存容器应密封,避免光照和高温。储存温度应控制在25℃以下,相对湿度应低于80%。避免与其...
什么是间甲苯异硫代异氰酸酯(CAS号:621-30-7)?
间甲苯异硫代异氰酸酯是一种有机化合物,分子式为C7H7NO2S,具有刺激性气味。它是一种重要的有机合成中间体,在合成其他化合物时广泛应用。
在合成中是否有N-Boc-D-苯丙氨醇(CAS号:106454-69-7)的替代品?
在合成中,可以考虑使用N-Cbz-D-苯丙氨醇或N-Fmoc-D-苯丙氨醇作为替代品。这些化合物同样具有保护氨基的功能,且在合成过程中表现出良好的反应性能。
3-羟甲基-2-氧异丙基吡啶(CAS号:954240-50-7)的主要用途是什么?
3-羟甲基-2-氧异丙基吡啶主要用于有机合成领域,可以作为合成其他药物、农药或精细化学品的中间体。此外,它还可能在实验室研究中作为特定反应的前体或溶剂。
6-氨基-9-甲基嘌呤(CAS号:700-00-5)应用于哪些行业?
6-氨基-9-甲基嘌呤目前主要应用于医药行业,作为某些药物的中间体。此外,它还可能用于聚合物、传感器和半导体的某些领域,作为功能性单体或掺杂剂。

![1-(Hexopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl 3-phenylacrylate structure 1-(Hexopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl 3-phenylacrylate structure](https://cnstatic.chemtradehub.com/structs/192/19210-12-9-ecae.webp)





